Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-012931
Filing Date
2023-08-02
Accepted
2023-08-02 16:25:48
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gbio-20230630x10q.htm   iXBRL 10-Q 1430218
2 EX-3.1 gbio-20230630xex3d1.htm EX-3.1 63093
3 EX-31.1 gbio-20230630xex31d1.htm EX-31.1 7619
4 EX-31.2 gbio-20230630xex31d2.htm EX-31.2 8136
5 EX-32.1 gbio-20230630xex32d1.htm EX-32.1 5103
6 EX-32.2 gbio-20230630xex32d2.htm EX-32.2 5082
  Complete submission text file 0001558370-23-012931.txt   5448236

Data Files

Seq Description Document Type Size
7 EX-101.SCH gbio-20230630.xsd EX-101.SCH 34911
8 EX-101.CAL gbio-20230630_cal.xml EX-101.CAL 34912
9 EX-101.DEF gbio-20230630_def.xml EX-101.DEF 160214
10 EX-101.LAB gbio-20230630_lab.xml EX-101.LAB 278612
11 EX-101.PRE gbio-20230630_pre.xml EX-101.PRE 247967
53 EXTRACTED XBRL INSTANCE DOCUMENT gbio-20230630x10q_htm.xml XML 844783
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Filer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39319 | Film No.: 231136109
SIC: 2834 Pharmaceutical Preparations